SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech trades jubilantly on getting certificate of Good Manufacturing Practices from SAHPRA

18 Apr 2022 Evaluate

Windlas Biotech is currently trading at Rs. 269.85, up by 33.60 points or 14.22% from its previous closing of Rs. 236.25 on the BSE.

The scrip opened at Rs. 246.00 and has touched a high and low of Rs. 280.00 and Rs. 241.40 respectively. So far 14834 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 452.10 on 16-Aug-2021 and a 52 week low of Rs. 208.90 on 31-Mar-2022.

Last one week high and low of the scrip stood at Rs. 280.00 and Rs. 235.00 respectively. The current market cap of the company is Rs. 594.22 crore.

The promoters holding in the company stood at 59.95%, while Institutions and Non-Institutions held 15.07% and 24.99% respectively.

Windlas Biotech has received certificate of Good Manufacturing Practices (GMP) from SAHPRA (South African Health Products Regulatory Authority). The company had undergone the inspection audit from September 20 to 29, 2021.

Windlas Biotech is into domestic pharmaceutical formulations contract development and manufacturing business.

Windlas Biotech Share Price

895.70 13.70 (1.55%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×